QuickView for Cyclin-dependent kinase inhibitor 1B (biogroup)

1. Peripheral blood mononuclear cells of type 2 diabetes mellitus patients
2. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
3. Embryonic stem cells differentiated in presence or absence of LIF
4. CD4+ T cells from Sle1b (lupus prone), Sle1b.BACSlamf6-H1 (rescued) and normal B6 mice
5. OMIM - Multiple endocrine neoplasia

There were no matches for Cyclin-dependent kinase inhibitor 1B

1. A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS
2. Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously…
3. AMG 193, Methylthioadenosine (MTA) Cooperative Protein Arginine Methyltransferase 5 (PRMT5) Inhibito…
4. Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer
5. Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bla…